Skip to content
OpenCapital
Get started

RadNet RDNT Proceeds from exercises of stock options and other stock issuances

Proceeds from exercises of stock options and other stock issuances at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
——

Other financials

Income statement

See full
Revenue$575.6M+22.1%
Operating income-$23.9M+0.8%
Net income-$33.5M+11.8%
EPS (diluted)-$0.43+15.7%

Balance sheet

See full
Cash & equivalents$455.3M-36.5%
Total debt$1.9B+10.8%
Total equity$1.1B+20.3%
Total assets$3.9B+16.5%

Cash flow

See full
Operating cash flow$79.0M+90.4%
CapEx$69.9M+43.2%
Free cash flow$9.0M+223%

Valuation

See full
Market cap$4.42B+17.8%

Profitability

See full
Gross margin13.4%—
Operating margin2.9%-0.8pp
Net margin-0.7%-0.3pp
FCF margin5.1%+0.9pp

Returns & leverage

See full
Return on equity-1.4%-0.5pp
Debt / equity1.8×-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by RadNet in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: RadNet’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about RadNet's proceeds from exercises of stock options and other stock issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RadNet's proceeds from exercises of stock options and other stock issuances?
RadNet (RDNT) reported proceeds from exercises of stock options and other stock issuances of $103K in Q1 2026.
How has RadNet's proceeds from exercises of stock options and other stock issuances changed year-over-year?
RadNet's proceeds from exercises of stock options and other stock issuances decreased by 14.9% year-over-year, from $121K to $103K.
What is the long-term trend for RadNet's proceeds from exercises of stock options and other stock issuances?
Over 3 years (2022 to 2025), RadNet's proceeds from exercises of stock options and other stock issuances has grown at a 164.6% compound annual growth rate (CAGR), from $294K to $5.45M.